Enhanced permeability and retention of macromolecular drugs in solid tumors: A royal gate for targeted anticancer nanomedicines

被引:469
|
作者
Greish, Khaled [1 ]
机构
[1] Sojo Univ, Fac Pharmaceut Sci, Lab Microbiol & Oncol, Kumamoto 8600082, Japan
基金
日本学术振兴会;
关键词
EPR effect; nanomedicines; micelles; targeted anticancer therapy; macromolecular drugs;
D O I
10.1080/10611860701539584
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Over the past two decades cancer has ascended the causes of human death to be number one or two in many nations world wide. A major limitation inherent to most conventional anticancer chemotherapeutic agents is their lack of tumor selectivity. One way to achieve selective drug targeting to solid tumors is to exploit abnormalities of tumor vasculature, namely, hypervascularisation; aberrant vascular architecture; extensive production of vascular permeability factors stimulating extravasation within tumor tissues, and lack of lymphatic drainage. Maeda and his colleagues have extensively studied tumor vascular abnormalities in terms of active and selective delivery of anticancer drugs to tumor tissues, notably defining the enhanced permeability and retention effect (EPR effect) of macromolecular drugs in solid tumors. Due to their large molecular size, nanosized macromolecular anticancer drugs administered intravenously (i.v.) escape renal clearance. Often they can not penetrate the tight enclothelial junctions of normal blood vessels, but they can extravasate in tumour vasculature and become trapped in the tumor vicinity. With time the tumor concentration will build up reaching several folds higher than that of the plasma due to lack of efficient lymphatic drainage in solid tumor; an ideal application for EPR-based selective anticancer drug delivery. Establishing this principle hastened development of various polymer conjugates and polymeric micelles as well as multifunctional nanoparticles for targeted cancer chemotherapy. Indeed this selective high local concentration of nanosized anticancer drugs in tumor tissues has proven superior in therapeutic effect with minimal side effects in both preclinical and clinical settings. In this review the mechanisms and factors involved in the EPR effect, as well as the uniqueness of nanoscale drugs for tumor targeting through EPR effect, will be discussed in detail.
引用
收藏
页码:457 / 464
页数:8
相关论文
共 50 条
  • [31] Anatomical Targeting of Anticancer Drugs to Solid Tumors Using Specific Administration Routes: Review
    Saito, Akira
    Kitayama, Joji
    Nagai, Ryozo
    Aizawa, Kenichi
    PHARMACEUTICS, 2023, 15 (06)
  • [32] A Drug-Eluting Injectable NanoGel for Localized Delivery of Anticancer Drugs to Solid Tumors
    Godau, Brent
    Samimi, Sadaf
    Seyfoori, Amir
    Samiei, Ehsan
    Khani, Tahereh
    Naserzadeh, Parvaneh
    Najafabadi, Alireza Hassani
    Lesha, Emal
    Majidzadeh-A, Keivan
    Ashtari, Behnaz
    Charest, Gabriel
    Morin, Christophe
    Fortin, David
    Akbari, Mohsen
    PHARMACEUTICS, 2023, 15 (09)
  • [33] Use of Molecular Biomarkers to Quantify the Spatial Distribution of Effects of Anticancer Drugs in Solid Tumors
    Saggar, Jasdeep K.
    Fung, Andrea S.
    Patel, Krupa J.
    Tannock, Ian F.
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (04) : 542 - 552
  • [34] Targeted drugs in combination with radiotherapy for the treatment of solid tumors: current state and future developments
    Selzer, Edgar
    Kornek, Gabriela
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2013, 6 (06) : 663 - 676
  • [35] The enhanced permeability and retention (EPR) effect in tumor vasculature: The key role of tumor-selective macromolecular drug targeting
    Maeda, H
    ADVANCES IN ENZYME REGULATION, VOL 41, 2001, 41 : 189 - 207
  • [36] Responsive nanomedicines enhanced by or enhancing physical modalities to treat solid cancer tumors: Preclinical and clinical evidence of safety and efficacy
    Papaioannou, Ligeri
    Avgoustakis, Konstantinos
    ADVANCED DRUG DELIVERY REVIEWS, 2022, 181
  • [37] Enhanced Nanodrug Delivery to Solid Tumors Based on a Tumor Vasculature-Targeted Strategy
    Song, Chenghua
    Zhang, Yejun
    Li, Chunyan
    Chen, Guangcun
    Kang, Xiaofeng
    Wang, Qiangbin
    ADVANCED FUNCTIONAL MATERIALS, 2016, 26 (23) : 4192 - 4200
  • [38] Limited penetration of anticancer drugs to cells in solid tumors: A neglected and modifiable cause of drug resistance.
    Tannock, IF
    Primeau, A
    Grantab, R
    Lee, C
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 852S - 852S
  • [39] Limited penetration of anticancer drugs through tumor tissue: A potential cause of resistance of solid tumors to chemotherapy
    Tannock, IF
    Lee, CM
    Tunggal, JK
    Cowan, DSM
    Egorin, MJ
    CLINICAL CANCER RESEARCH, 2002, 8 (03) : 878 - 884
  • [40] Targeted drug delivery to solid tumors using thermally responsive elastin-like polypeptide macromolecular drug carriers
    Dreher, Matthew R.
    Liu, Wenge
    Zalutsky, Michael R.
    Dewhirst, Mark W.
    Chilkoti, Ashutosh
    CANCER RESEARCH, 2006, 66 (08)